Picture [MSC] – The Mass Spectrometry Web Portal 600x80px
Organisation › Details

Cellectis S.A. (Euronext Growth: ALCLS, Nasdaq: CLLS)

Cellectis is a pioneer in the field of genome engineering. The company designs and markets innovative tools – meganucleases. These molecular scissors enable targeted modifications to DNA, with applications in the research, biomanufacturing, agrobiotechnology and therapeutic sectors. To date, Cellectis has formed over 20 academic research partnerships and has established more than 50 agreements with pharmaceutical laboratories, seed producers and biotech companies across the world. The company holds exclusive rights to a portfolio of over 260 patents granted or pending. Since 2007, Cellectis has been listed on the NYSE-Euronext Alternext market (code: ALCLS) in Paris and has secured over €70 million in funding since inception. *


Period Start 1999-01-01 established
  Group Cellectis (Group)
Products Industry genome editing (gene editing)
  Industry 2 TALEN (Transcription Activator-Like Effector Nuclease)
Persons Person Choulika, André (Cellectis 200701 CEO + co-founder)
  Person 2 Dutang, Eric (Cellectis 2016– CFO joined 201505)
Region Region Romainville
  Country France
  Street 8 Rue de la Croix Jarry
  City 75013 Paris
  Tel +33-1-8169-1600
    Address record changed: 2015-04-24
Basic data Employees D: 101 to 500 (2016-12-31)
  Currency EUR
  Annual sales 51,007,000 (income, total, consolidated (2016) 2016-12-31)
  Profit -60,776,000 (2016-12-31)
  Cash 237,600,000 (2017-06-30)
    * Document for »About Section«: 
Record changed: 2018-02-23


Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 600x60px

More documents for Cellectis (Group)

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Fairtec GmbH Worldwide Event Solutions 600x60px

» top


Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Picture [LSE] – The Business Web Portal 120x600px Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 120x240px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px